APP to help fill any heparin shortage
SCHAUMBURG -- APP Pharmaceuticals Inc. said Tuesday that, in response to FDA and hospital concerns about a potential shortage of heparin, it will immediately increase manufacturing of its multi-dose vials of this blood thinner. APP said it acquires its active ingredient, heparin USP, from multiple manufacturers that have been inspected and approved by the FDA, including its supplier from China.
Article Comments
Guidelines: Keep it civil and on topic; no profanity, vulgarity, slurs or personal attacks. People who harass others or joke about tragedies will be blocked.
If a comment violates these standards or our terms of service, click the "flag" link in the lower-right corner of the comment box. To find our more, read our FAQ.